Internal Medicine, Pulmonary Disease · Chicago, IL
NPI
1619030137
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
5841 S Maryland Ave
Chicago, IL, 60637
Phone (888) 824-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
686 services
Medicare patients, 2024
323
Average age 72
Drug cost, 2024
$3.7M
1,220 prescriptions
Company payments, 2025
$426K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas Hogarth was code 99213 (office e&m - established), 220 times for 160 patients. In total Douglas Hogarth billed 686 services in 34 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 220 | 160 | $52.34 | $12K |
| 99204 Office E&M - New | Facility | 88 | 88 | $112.99 | $9,944 |
| 31628 Bronchoscopy | Facility | 53 | 53 | $68.42 | $3,626 |
| 31627 Bronchoscopy | Facility | 51 | 51 | $86.27 | $4,400 |
| 31629 Bronchoscopy | Facility | 49 | 49 | $113.52 | $5,563 |
| 31654 Bronchoscopy | Facility | 36 | 36 | $59.54 | $2,144 |
| 32555 Other Organ Systems | Facility | 24 | 21 | $91.06 | $2,186 |
| 31653 Bronchoscopy | Facility | 24 | 24 | $203.41 | $4,882 |
| 31624 Bronchoscopy | Facility | 21 | 19 | $107.77 | $2,263 |
| 31626 Bronchoscopy | Facility | 18 | 18 | $93.96 | $1,691 |
| 31647 Bronchoscopy | Facility | 14 | 14 | $182.47 | $2,555 |
| 31652 Bronchoscopy | Facility | 12 | 12 | $163.48 | $1,962 |
By year: 2022 $46K for 547 services; 2023 $60K for 715 services; 2024 $59K for 686 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas Hogarth prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 136 prescriptions and refills. In total Douglas Hogarth wrote 1,220 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 136 | 160 | 42 | $4,527 |
| Prolastin C Alpha-1-Proteinase Inhibitor | 97 | 97 | 11 | $1.0M |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 92 | 145 | 21 | $87K |
| Prednisone Generic | 89 | 101 | 37 | $328 |
| Spiriva Respimat Tiotropium Bromide | 66 | 116 | 15 | $59K |
| Glassia Alpha-1-Proteinase Inhibitor | 65 | 65 | Under 11 | $1.0M |
| Azithromycin Generic | 52 | 62 | 24 | $229 |
| Spiriva Handihaler Tiotropium Bromide | 43 | 87 | 12 | $41K |
| Incruse Ellipta Umeclidinium Bromide | 43 | 57 | Under 11 | $19K |
| Symbicort Budesonide/Formoterol Fumarate | 39 | 65 | Under 11 | $15K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 32 | 42 | Under 11 | $25K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 28 | 48 | Under 11 | $5,727 |
| Aralast Np Alpha-1-Proteinase Inhibitor | 28 | 28 | Under 11 | $383K |
| Breo Ellipta Fluticasone/Vilanterol | 27 | 49 | Under 11 | $18K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 25 | 31 | Under 11 | $14K |
Brand drugs: 890 claims; generic drugs: 330 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas Hogarth $426K ($426K in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $172K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 179 | $172K |
| Noah Medical Corporation | 194 | $142K |
| Grifols USA, LLC | 40 | $48K |
| Olympus America Inc. | 56 | $30K |
| Pulmonx Corporation LUNG | 23 | $13K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 20 | $9,652 |
| Olympus Corporation of the Americas | 5 | $6,412 |
| Genzyme Corporation SNY | 3 | $3,236 |
| Serpex Medical Inc | 2 | $1,159 |
| Ambu A/S AMBBY | 1 | $520 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.